News
The article Is IDEXX Laboratories a Fast Cash Machine? originally appeared on Fool.com. Seth Jayson had no position in any company mentioned here at the time of publication.
The article Is IDEXX Laboratories's Cash Machine Slowing Down? originally appeared on Fool.com. Seth Jayson had no position in any company mentioned here at the time of publication.
The IDEXX Hematology portfolio, including the ProCyte One analyzer, ProCyte Dx® analyzer, and IDEXX Reference Laboratories' CBC testing, offers the most accurate and comprehensive CBC testing ...
--IDEXX Laboratories, Inc., a global leader in veterinary diagnostics and software, announced today the launch of the ProCyte One™ Hematology Analyzer. The ProCyte One Hematology Analyzer is ...
See our latest analysis for IDEXX Laboratories To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine.
Idexx Labs posted first-quarter performance that featured significant pricing gains, and after tweaking our full-year projections to accommodate these changes, we’ve modestly raised our fair ...
IDEXX Laboratories, Inc. (NASDAQ: IDXX) Q1 2019 Earnings Conference Call May 1, 2019 8:30 AM ET Company Participants Brian McKeon – Chief Financial Officer Jon Ayers – Chief Executive Officer ...
The CCC figure for IDEXX Laboratories for the trailing 12 months is 109.6. For younger, fast-growth companies, the CCC can give you valuable insight into the sustainability of that growth.
Today, we'll see how it applies to IDEXX Laboratories (Nasdaq: IDXX). Let's break this down In this series, we measure how swiftly a company turns cash into goods or services and back into cash.
The IDEXX Hematology portfolio, including the ProCyte One analyzer, ProCyte Dx® analyzer, and IDEXX Reference Laboratories' CBC testing, offers the most accurate and comprehensive CBC testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results